Protocol sheets, compliance guides, and regulatory briefings built for compounding pharmacy teams, functional medicine practitioners, and sales professionals.
The peptide space is moving fast and the regulatory landscape is shifting weekly. Peptide Academy Professional gives practitioners and sales teams the clinical clarity to navigate it.
Understand your formulary at a mechanistic level. Know what you can say, what's restricted, and how to position compounds accurately to prescribers.
Rapid-reference protocol sheets for patient conversations. Mechanism, dosing ranges, contraindications, and current research — formatted for clinical use.
Adding peptide protocols to your menu? Get the clinical framework your staff needs to consult confidently, plus compliance guidance for your jurisdiction.
Stay ahead of what physicians are asking. Our regulatory briefings track FDA panel developments and compounding rule changes in plain language, in real time.
Evidence-based summaries on recovery and performance peptides, including WADA/USADA ban status for each compound — critical for athlete consultations.
Patients are coming in with questions about peptides they found online. Get the background to guide them to evidence-based decisions, not internet protocols.
Every resource is reviewed for accuracy, formatted for clinical utility, and updated when the regulatory landscape shifts.
One-page summaries for each compound: mechanism of action, indications researched, dosing ranges, administration routes, contraindications, drug interactions, and citation list. Formatted for clinical settings.
View sample →What you can and cannot say about each compound under current FDA compounding rules. Updated after every regulatory development. Includes the July 2026 panel impact analysis.
Read the guide →Plain-language briefings on every FDA compounding rule development. Understand the 503A/503B framework, Category 1 vs 2 status, and what each change means for your formulary or practice.
Latest briefing →How to discuss peptide protocols with prescribers accurately and within compliance boundaries. Includes common objections, evidence gaps to acknowledge, and appropriate clinical framing.
Coming Month 2Every compound categorized by evidence quality: strong preclinical, emerging human data, or limited evidence. No overstating what the science shows. Essential for accurate clinical conversations.
Coming Month 2Need to onboard a sales team or clinical staff? Team licenses cover unlimited users at a single organization. Custom branded protocol sheets available for enterprise clients.
Contact us →The April 15 Federal Register notice temporarily removed seven peptides from the Category 2 restricted list. That creates an ambiguous window — some pharmacies are compounding again, but formal rulemaking hasn't happened. Sales conversations require precision.
All plans include access to the full consumer protocol library plus professional-tier resources. Cancel anytime.
Weekly regulatory updates and clinical notes for practitioners in the peptide space. Free. No spam.
Join practitioners and sales professionals already subscribed.
Curated tools, devices, and supplements used across the recovery, longevity, and peptide research community.
Protocol breakdowns, FDA regulatory updates, research summaries, and compliance news for practitioners — every day.
Follow @peptide_academy